ArticlePloS one2016

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

Tarik Asselah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.